Susan G. Komen® Invites Donors to Tie Their Dollars to Their Passions Through New Donation Program at

Supporters Can Donate Directly to Komen’s Metastatic Breast Cancer
Research, General Breast Cancer Research or Patient Support and
Education Programs through Pilot Program Launching Today

DALLAS–(BUSINESS WIRE)–Breast cancer donors will be able to contribute directly to specific
breast cancer research and support programs that they care deeply about,
through a pilot program launched today by Susan G. Komen at its national

“Many of our friends and supporters tell us that while they appreciate
the depth and breadth of Komen’s mission, they’d like to be able to
donate specifically to work that has special meaning to them,” said Dr.
Judy Salerno, Komen’s President and CEO. “We’re delighted to provide
that option on our website,, during National Breast Cancer
Awareness Month in October – a month where the fight against breast
cancer is top of mind and people are eager to make a difference.”

Starting today and for the month of October, Komen is offering donors
the opportunity to contribute specifically to Komen’s metastatic
breast cancer
research program, Komen’s general research
program, Komen’s national support and education programs or
Komen’s general fund.

The organization timed the launch of the program to coincide with
Metastatic Breast Cancer Awareness Day today (Oct. 13).

“Metastatic Breast Cancer Awareness Day has special significance for us
at Komen, because our friends and loved ones are among the 40,000 women
and men who die of metastatic disease each year,” Salerno said. “We’re
committed to changing those terrible numbers by finding better
treatments and cures for metastatic disease while supporting metastatic

She noted that while Komen has funded more metastatic research than any
other nonprofit – $147 million to date, including funding for 36 new
metastatic research grants in 2015 – there is still much more work to be
done. Komen also is a founding member of the Metastatic Breast Cancer
Alliance, a consortium formed in 2013 by more than two dozen
organizations to advance the issues of metastatic patients.

Donors wishing to contribute specifically to metastatic research
programs can do so here.

Other areas donors can directly support include:

  • Komen’s general research program invests in research along the
    entire breast cancer continuum from prevention to better screening
    methodologies, to precision medicine and better therapies and cures
    for breast cancer. At $889 million since inception, Komen has made the
    largest nonprofit investment in breast cancer research, second only to
    the federal government.
  • Komen’s national support and education programs, such as
    Komen’s national helpline, which in the last fiscal year responded to
    more than 15,000 women, men and families facing breast cancer to
    provide information on lifesaving financial, educational, treatment
    and psychosocial support resources. Komen’s educational messaging
    about breast health and breast cancer reaches millions of people
    through a variety of means, most importantly through our “About Breast
    Cancer” web pages, which were accessed more than 3.6 million times
    this past year. And, through its national Community Health grant
    program, Komen makes screening, treatment, and patient navigation
    possible in communities nationwide.
  • Komen’s general fund. Donations may be used to fund any of the
    previously mentioned mission programs or general administrative costs.

Salerno said Komen will evaluate the program with an eye toward offering
future opportunities to donate directly to Komen programs, including
Komen’s minority health, breast cancer prevention, environmental
research and young investigator programs.

Funds raised by the program will augment, but not replace, money raised
through other events such as Komen’s Race for the Cure series or
partnership programs.

Research grant applications will be subject to Komen’s nationally
recognized peer review process, which calls together more than 60
patient advocates, leading breast cancer scientists and clinical
researchers to evaluate new granting.

About Susan G. Komen®

Susan G. Komen is the world’s largest breast cancer organization,
funding more breast cancer research than any other nonprofit while
providing real-time help to those facing the disease. Since its founding
in 1982, Komen has funded more than $889 million in research and
provided $1.95 billion in funding to screening, education, treatment and
psychosocial support programs serving millions of people in more than 30
countries worldwide. Komen was founded by Nancy G. Brinker, who promised
her sister, Susan G. Komen, that she would end the disease that claimed
Suzy’s life. Visit or call 1-877 GO KOMEN. Connect with us on
social at


Susan G. Komen
Andrea Rader, 972-855-4382